Literature DB >> 16200064

Probing tumor phenotypes using stable and regulated synthetic microRNA precursors.

Ross A Dickins1, Michael T Hemann, Jack T Zilfou, David R Simpson, Ingrid Ibarra, Gregory J Hannon, Scott W Lowe.   

Abstract

RNA interference is a powerful method for suppressing gene expression in mammalian cells. Stable knock-down can be achieved by continuous expression of synthetic short hairpin RNAs, typically from RNA polymerase III promoters. But primary microRNA transcripts, which are endogenous triggers of RNA interference, are normally synthesized by RNA polymerase II. Here we show that RNA polymerase II promoters expressing rationally designed primary microRNA-based short hairpin RNAs produce potent, stable and regulatable gene knock-down in cultured cells and in animals, even when present at a single copy in the genome. Most notably, by tightly regulating Trp53 knock-down using tetracycline-based systems, we show that cultured mouse fibroblasts can be switched between proliferative and senescent states and that tumors induced by Trp53 suppression and cooperating oncogenes regress upon re-expression of Trp53. In practice, this primary microRNA-based short hairpin RNA vector system is markedly similar to cDNA overexpression systems and is a powerful tool for studying gene function in cells and animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200064     DOI: 10.1038/ng1651

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  261 in total

1.  Cutting edge: microRNA regulation of macrophage fusion into multinucleated giant cells.

Authors:  James R Sissons; Jacques J Peschon; Frank Schmitz; Rosa Suen; Mark Gilchrist; Alan Aderem
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  A versatile single-plasmid system for tissue-specific and inducible control of gene expression in transgenic mice.

Authors:  Jae-Kyun Ko; Kyoung-Han Choi; Xiaoli Zhao; Shinji Komazaki; Zui Pan; Noah Weisleder; Jianjie Ma
Journal:  FASEB J       Date:  2011-04-25       Impact factor: 5.191

3.  A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress.

Authors:  Peter M Bruno; Yunpeng Liu; Ga Young Park; Junko Murai; Catherine E Koch; Timothy J Eisen; Justin R Pritchard; Yves Pommier; Stephen J Lippard; Michael T Hemann
Journal:  Nat Med       Date:  2017-02-27       Impact factor: 53.440

4.  Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy.

Authors:  Xu Tan; Zhi John Lu; Geng Gao; Qikai Xu; Long Hu; Christof Fellmann; Mamie Z Li; Hongjing Qu; Scott W Lowe; Gregory J Hannon; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

5.  Role of human DNA glycosylase Nei-like 2 (NEIL2) and single strand break repair protein polynucleotide kinase 3'-phosphatase in maintenance of mitochondrial genome.

Authors:  Santi M Mandal; Muralidhar L Hegde; Arpita Chatterjee; Pavana M Hegde; Bartosz Szczesny; Dibyendu Banerjee; Istvan Boldogh; Rui Gao; Maria Falkenberg; Claes M Gustafsson; Partha S Sarkar; Tapas K Hazra
Journal:  J Biol Chem       Date:  2011-11-30       Impact factor: 5.157

6.  Involvement of Beclin 1 in engulfment of apoptotic cells.

Authors:  Akimitsu Konishi; Satoko Arakawa; Zhenyu Yue; Shigeomi Shimizu
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

7.  Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance.

Authors:  Maria Hinterberger; Martin Aichinger; Olivia Prazeres da Costa; David Voehringer; Reinhard Hoffmann; Ludger Klein
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

8.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

9.  ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence.

Authors:  Linan Ha; Takeshi Ichikawa; Miriam Anver; Ross Dickins; Scott Lowe; Norman E Sharpless; Paul Krimpenfort; Ronald A Depinho; Dorothy C Bennett; Elena V Sviderskaya; Glenn Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

10.  Loss of p53 impedes the antileukemic response to BCR-ABL inhibition.

Authors:  Hans-Guido Wendel; Elisa de Stanchina; Enriqué Cepero; Sagarika Ray; Michael Emig; Jordan S Fridman; Darren R Veach; William G Bornmann; Bayard Clarkson; W Richard McCombie; Scott C Kogan; Andreas Hochhaus; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.